跳至主要内容
临床试验/NL-OMON23346
NL-OMON23346招募中不适用

High dose immunoablation and autologous hematopoietic stem cell transplantation versus monthly intravenous pulse therapy.

EBMT/EULAR Working Party Autoimmune Diseases.0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200

研究概览

简要总结

van Laar JM, Farge D, Tyndall A, on behalf of the EBMT/EULAR Scleroderma Study Group. Stem cell transplantation in systemic sclerosis: hope on the horizon. Ann Rheum Dis 2005, in press.

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with diffuse systemic sclerosis, aged 16-65 yrs, and:
  • 1. Disease duration 4 years or less, plus evidence of heart, lung or kidney involvement, plus skin score 15 or more, or:

排除标准

  • Patients with concomitant severe disease, extensive pretreatment according to predefined criteria with cyclophosphamide are excluded.

研究者

发起方
EBMT/EULAR Working Party Autoimmune Diseases.

相似试验